Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Staphylococcus aureus bacteremia.

Allan Garlik Jensen1

  • 1Sector for Microbiology, Statens Serum Institut, Copenhagen.

Danish Medical Bulletin
|December 26, 2003
PubMed
Summary

Staphylococcus aureus bacteremia (SAB) risk factors include central venous catheters, nasal carriage, hyponatremia, and anemia. Optimal treatment involves focus eradication and specific antibiotic dosing for better outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000.

The Pediatric infectious disease journal·2007
See all related articles

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Background:

  • Staphylococcus aureus bacteremia (SAB) is a significant cause of mortality with limited understanding of risk factors and treatment.
  • Metastatic infections, including osteomyelitis and meningitis, are common complications of SAB.

Purpose of the Study:

  • To investigate risk factors for hospital-acquired SAB.
  • To evaluate antibiotic treatment strategies for SAB.
  • To analyze the clinical aspects, diagnosis, and treatment of S. aureus osteomyelitis and meningitis secondary to SAB.

Main Methods:

  • Case-control studies to identify risk factors for SAB.
  • Logistic regression analysis to assess antibiotic treatment efficacy.
  • Retrospective analysis of a nationwide registry for S. aureus infections (osteomyelitis, meningitis).

Main Results:

  • Central venous catheter, nasal S. aureus carriage, hyponatremia, and anemia are key risk factors for hospital-acquired SAB.
  • Focus eradication is essential for SAB treatment; higher dicloxacillin doses (1g x 4 or 2g x 3) showed superior outcomes compared to 1g x 3.
  • Diagnosis of vertebral osteomyelitis requires advanced imaging (CT, bone scintigraphy); treatment necessitates penicillinase-stable penicillins (4g daily for ≥8 weeks).
  • S. aureus meningitis is rare, often community-acquired in older patients with comorbidities, and associated with extremely high mortality.

Conclusions:

  • Identifying and managing risk factors can reduce SAB incidence.
  • Optimized antibiotic dosing and focus eradication are crucial for effective SAB treatment.
  • Early diagnosis and prolonged, specific antibiotic therapy are vital for managing S. aureus osteomyelitis and meningitis, though outcomes remain poor for meningitis.

Related Experiment Videos